LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2705 | 4513 | 0.5993 | 0.4482 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3535 | 4513 | 0.7833 | 0.7016 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4641 | 4513 | 1.0282 | 1.0389 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4176 | 4513 | 0.9253 | 0.8972 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2577 | 4513 | 0.5711 | 0.4094 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4311 | 4513 | 0.9551 | 0.9382 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1541 | 4513 | 0.3415 | 0.0932 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 956 | 4513 | 0.2120 | -0.0852 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1351 | 4513 | 0.2995 | 0.0353 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1305 | 4513 | 0.2891 | 0.0211 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3605 | 4513 | 0.7987 | 0.7228 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4371 | 4513 | 0.9684 | 0.9565 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1003 | 4513 | 0.2222 | -0.0711 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 1235 | 978 | 4513 | 0.2168 | -0.0785 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1697 | 4513 | 0.3760 | 0.1407 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 446 | 4513 | 0.0989 | -0.2409 |
MDA-MB-231 | XMD11-50 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2134 | 4513 | 0.4729 | 0.2741 |
MDA-MB-231 | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2999 | 4513 | 0.6646 | 0.5381 |
MDA-MB-231 | YM 201636 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3223 | 4513 | 0.7141 | 0.6063 |
MDA-MB-231 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2846 | 4513 | 0.6307 | 0.4914 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2749 | 4513 | 0.6090 | 0.4616 |
MDA-MB-231 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4244 | 4513 | 0.9403 | 0.9178 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 447 | 4513 | 0.0992 | -0.2405 |
MDA-MB-231 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 283 | 4513 | 0.0628 | -0.2905 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 594 | 4513 | 0.1317 | -0.1958 |